Correlation Between Processa Pharmaceuticals and Pulmatrix

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Pulmatrix, you can compare the effects of market volatilities on Processa Pharmaceuticals and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Pulmatrix.

Diversification Opportunities for Processa Pharmaceuticals and Pulmatrix

-0.77

Correlation Coefficient

Processa Pharmaceuticals  Pulmatrix

Pay attention - limited upside

The 3 months correlation between Processa and Pulmatrix is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Pulmatrix go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Pulmatrix

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Pulmatrix. In addition to that, Processa Pharmaceuticals is 2.06 times more volatile than Pulmatrix. It trades about -0.02 of its total potential returns per unit of risk. Pulmatrix is currently generating about 0.04 per unit of volatility. If you would invest  381.00  in Pulmatrix on September 3, 2024 and sell it today you would earn a total of  283.00  from holding Pulmatrix or generate 74.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Pulmatrix

Processa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pulmatrix

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Processa Pharmaceuticals and Pulmatrix

The main advantage of trading using opposite Processa Pharmaceuticals and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.

The idea behind Processa Pharmaceuticals and Pulmatrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.